JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 1,764 articles

Articles by James Calloway

SoFi shares flat after record Q1, tech platform revenue drops 27%
Earnings

SoFi shares flat after record Q1, tech platform revenue drops 27%

SoFi shares were flat Monday after record Q1 results, with net revenue up 43% to $1.10B but technology platform revenue down 27%.

SOFI HOOD AFRM NU
Costco Shares Surge Amid Consumer Caution; Valuation Stays Elevated
Earnings

Costco Shares Surge Amid Consumer Caution; Valuation Stays Elevated

Costco shares climbed to $1,064.98 as April sales rose 13% to $23.92B. The company raised its dividend and will report fiscal Q3 earnings on May 28.

COST WMT TGT
Broadcom's AI Chip Surge Faces Key Earnings Test in June
Earnings

Broadcom's AI Chip Surge Faces Key Earnings Test in June

Broadcom shares fell 1.6% to $418.45 as UBS raised its price target to $490. The chipmaker's June 3 earnings will test whether custom AI chip demand can support its $2T valuation.

AVGO GOOGL META NVDA AMD MRVL
Apellis Delisted After Biogen Buyout; CVR Payout in Focus
Earnings

Apellis Delisted After Biogen Buyout; CVR Payout in Focus

Apellis Pharmaceuticals has been delisted from Nasdaq following Biogen's completed acquisition. Shareholders get $41 per share plus a contingent value right worth up to $4 if Syfovre meets sales goals.

BIIB APLS
Analysts Boost Walmart Targets Ahead of Q1 Earnings Report
Earnings

Analysts Boost Walmart Targets Ahead of Q1 Earnings Report

Walmart shares gained 0.8% Monday after multiple Wall Street analysts raised price targets ahead of the retailer's fiscal first-quarter earnings report on Thursday.

WMT
Baidu Surges on AI Cloud Strength Despite Advertising Decline
Earnings

Baidu Surges on AI Cloud Strength Despite Advertising Decline

Baidu's U.S.-listed shares rallied over 3% premarket as Q1 revenue topped forecasts, with AI cloud revenue surging 49% to offset a 22% drop in online marketing.

BIDU BABA
Ryanair Warns Summer Fares Flat, Record Profit Fails to Lift Shares
Earnings

Ryanair Warns Summer Fares Flat, Record Profit Fails to Lift Shares

Ryanair warned peak summer fares will be flat, reversing earlier expectations, citing late bookings and fuel costs. Shares fell over 3% despite a record annual profit of €2.26 billion.

NextNRG Stock Surges 99% After Hours on Q1 Revenue Growth
Earnings

NextNRG Stock Surges 99% After Hours on Q1 Revenue Growth

NextNRG stock surged nearly 99% in after-hours Friday after reporting 29% revenue growth. The company's net loss widened, but management highlights reduced interest expense and improving unit economics.

IonQ Faces Investor Scrutiny After Mixed Week Despite Revenue Surge
Earnings

IonQ Faces Investor Scrutiny After Mixed Week Despite Revenue Surge

IonQ shares ended a turbulent week down 9.6% on Friday, despite a 755% revenue surge in Q1. The quantum computing firm's heavy spending and cash burn continue to fuel investor debate.

IONQ QBTS RGTI
Ambev's Post-Earnings Rally Stalls; World Cup Hopes Tested Next Week
Earnings

Ambev's Post-Earnings Rally Stalls; World Cup Hopes Tested Next Week

Ambev shares fell 0.51% on Friday, pausing after a strong Q1 earnings report. Investors now focus on the World Cup's potential to boost beer demand, with the stock up 13.2% YTD.

Netflix's Ad Push Faces Market Test as Stock Holds Steady
Earnings

Netflix's Ad Push Faces Market Test as Stock Holds Steady

Netflix shares closed at $87.02 Friday, up 0.09% but down 0.5% from last week. The company announced its ad-supported plan now reaches over 250 million global viewers, with expansion to 15 more countries by 2027.

NFLX GOOGL DIS
Pfizer Faces Investor Scrutiny After Weekly Decline Amid Pipeline Concerns
Earnings

Pfizer Faces Investor Scrutiny After Weekly Decline Amid Pipeline Concerns

Pfizer shares dropped 1.63% on Friday to $25.33, lagging the S&P 500. Despite a 5% revenue increase and reaffirmed 2026 guidance, investor caution persists over pipeline risks and competitive pressure from Eli Lilly.

PFE LLY BMY NVDA WMT